Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Fall Home Improvement
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Alzheimer's disease
Recent news which mentions Alzheimer's disease
< Previous
1
2
3
Next >
Alzheimer's Progression Slowed Down By Biogen's New Drug In Late-Stage Study: Analyst Sees 25% Upside For Stock
September 28, 2022
Tickers
BIIB
ESALY
Tags
Marc Goodman
Analyst Color
News
From
Benzinga
Following Up on Your Suggestions – September 2022
September 26, 2022
Tickers
DIET
Tags
vitamins
Roche (RHHBF RHHBY)
NervGen Pharma (NGEN/V NGENF)
From
Stock Gumshoe
Alzheimer's Disease: A New Generation of Screenings and Therapies on the Horizon
August 10, 2022
Tickers
DGX
Tags
Alzheimer's Disease
Events, Media & Communications
NYSE:DGX
From
3BL Media: Corporate Social Responsibility, Energy and Health News
EXCLUSIVE: Cognition Therapeutics Shares Biomarker Data From Alzheimer's Candidate
August 04, 2022
Tickers
CGTX
Tags
Biotech
News
Alzheimer's disease
From
Benzinga
Alzheimer’s Drug Development — July Responses to Questions & Requests
July 19, 2022
Tags
Genting Berhad (GEBHY)
Doc Gumshoe
Alzheimer's Disease
From
Stock Gumshoe
AbbVie Dumps An Early-Alzheimer's Candidate Developing In Collaboration With Alector
July 08, 2022
Tickers
ABBV
ALEC
Tags
Market News
Benzinga
Biotech
From
Benzinga
Alzheimer’s Disease June 2022 – Possible Signs of Progress
June 13, 2022
Tags
TauRX Pharmaceuticals
Cassava Sciences (SAVA)
Alzheimer's Disease
From
Stock Gumshoe
Researchers Investigate New Treatment Pathways For Alzheimer's After Commercial Failure Of Biogen's Aduhelm
May 23, 2022
Tickers
BIIB
Tags
General
Health Care
Aduhelm
From
Benzinga
Alzheimer’s Disease May 2022 – Is There Anything New?
May 10, 2022
Tags
inflammation
Biogen Idec (BIIB)
Eisai (ESALY)
From
Stock Gumshoe
Eisai - Biogen Seek Accelerated Approval For Their Second Alzheimer's Drug
May 10, 2022
Tickers
BIIB
ESALF
ESALY
Tags
Market News
Benzinga
FDA
From
Benzinga
New York Times Report Fresh Allegations On Cassava's Simufilam Alzheimer's Trials, Shares Fall
April 19, 2022
Tickers
SAVA
Tags
Trading Ideas
Benzinga
Market News
From
Benzinga
EXCLUSIVE: Longeveron Adds Miami Veterans Affairs Site To Its Ongoing Mid-Stage Alzheimer's Trial
April 13, 2022
Tickers
LGVN
Tags
Benzinga
Market News
Phase 2 Trial
From
Benzinga
Biogen's Alzheimer's Drug Aduhelm Medicare Coverage Restricted To Just Clinical Trials, CMS Finalizes
April 08, 2022
Tickers
BIIB
Tags
Top Stories
Aduhelm
General
From
Benzinga
EXCLUSIVE: Longeveron's Lomecel-B Data In Alzheimer's Disease Published In Medical Journal
March 31, 2022
Tickers
LGVN
Tags
Exclusives
News
General
From
Benzinga
Biogen, Eisai Unveil New Data On Another Alzheimer's Candidate, Lecanemab
March 22, 2022
Tickers
BIIB
ESALF
ESALY
Tags
General
ESALY
News
From
Benzinga
Biogen Shares Aduhelm Data In Alzheimer's Disease At 128 Weeks
March 16, 2022
Tickers
BIIB
Tags
Alzheimer's disease
News
Briefs
From
Benzinga
Prothena Highlinghts New Preclinical Data For Alzheimer's, Parkinson's Vaccine Programs
March 16, 2022
Tickers
PRTA
Tags
PRTA
Parkinson’s Disease
Market News
From
Benzinga
Gain Therapeutics Posts Encouraging Preclinical Data From Parkinson's, Alzheimer's Programs
March 15, 2022
Tickers
GANX
Tags
News
Briefs
Movers
From
Benzinga
Biogen, Eisai Amend Their Alzheimer's Drug Marketing Pact
March 15, 2022
Tickers
BIIB
ESALF
ESALY
Tags
ESALF
News
Briefs
From
Benzinga
AC Immune-Janssen Partnered Alzheimer's Vaccine Shows Tau-Specific Antibodies In Early-Stage Trial
February 15, 2022
Tickers
ACIU
JNJ
Tags
Biotech
Small Cap
Alzheimer's disease
From
Benzinga
Eli Lilly Plans To Invest €400M In Manufacturing Facility In Ireland: Report
January 28, 2022
Tickers
LLY
Tags
Biotech
News
Alzheimer's disease
From
Benzinga
Cortexyme Stock Plunges On FDA Hold On Atuzaginstat's IND
January 26, 2022
Tickers
CRTX
Tags
General
Movers
Briefs
From
Benzinga
FDA Places Clinical Hold On Denali's Alzheimer's Potential Program
January 13, 2022
Tickers
DNLI
Tags
Market News
Trading Ideas
Benzinga
From
Benzinga
CMS Proposes Coverage Of Biogen's Alzheimer's Drug, With Conditions Apply
January 12, 2022
Tickers
BIIB
ESALF
ESALY
LLY
Tags
Movers
ESALY
why it's moving
From
Benzinga
Exclusive: Longeveron Kickstarts Its Mid-Stage Alzheimer's Disease Trial
January 05, 2022
Tickers
LGVN
Tags
Alzheimer's disease
News
LGVN
From
Benzinga
Why Hoth Therapeutics Stock Is Soaring Today?
January 04, 2022
Tickers
HOTH
Tags
Alzheimer's disease
Biotech
Preclinical Phase
From
Benzinga
Why Biogen's Alzheimer's drug Aduhelm is so controversial
January 04, 2022
Tags
Health insurance
US: News
Baby Boomers
From
CNBC.com News
Medicare Trying To Determine Coverage Of Biogen's Expensive Alzheimer's Drug: NYT
January 03, 2022
Tickers
BIIB
Tags
Biotech
News
Alzheimer's disease
From
Benzinga
Acadia Slims Nuplazid Label Expansion Application For Alzheimer's Disease Psychosis
December 21, 2021
Tickers
ACAD
Tags
Market News
Trading Ideas
FDA
From
Benzinga
After Much Criticism, Biogen Slashes Aduhelm Price In Half
December 20, 2021
Tickers
BIIB
Tags
Briefs
News
Movers
From
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.